| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |